Patent Yard Sign in
Canadian application, no grantCanada

Benzodiazepine analogs

CA 2056809 A1 · Owner: Bock, Mark G. · Inventors: Evans, Ben E.; Bock, Mark G.; Freidinger, Roger M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Benzodiazepine analogs of the formula: I, are disclosed which are antagonists of gastrin and cholecystokinin (CCK) with enhanced aqueous solubility and have properties useful in the treatment of panic disorder, anxiety disorder oncologic disorders, treating pain or inducing analgesia, or treating a withdrawal response produced by treatment or abuse of drugs or alcohol.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 2, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 2, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 2, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 2, 1991
GrantedNo grant recorded
Term endedDecember 2, 2011
Patent numberCA 2056809 A1
Classification (IPC)C07D243/14 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedDec 2, 1991Term endedDec 2, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.